Related Experiment Video
Updated: Jun 5, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
High-level polyomavirus JC viruria following long-term steroid therapy
Cristina Costal1, Massimiliano Bergallo, Paolo Ferrara
1S.C.D.U. Virologia, Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino. cristina.costa@unito.it
JC virus (JCV) causes persistent infections, typically asymptomatic. A case study reveals high-level asymptomatic JC viruria in an immunocompetent patient after long-term steroid therapy.
Area of Science:
- Virology
- Immunology
Background:
- JC virus (JCV) is a common polyomavirus causing persistent, usually asymptomatic infections.
- JCV establishes latency in tissues like the brain and genitourinary tract.
- Unlike BK polyomavirus, JC viruria is nearly universal in healthy adults.
Observation:
- This study details a case of an immunocompetent patient.
- The patient presented with exceptionally high levels of asymptomatic JC viruria.
- This condition occurred after a prolonged course of steroid therapy.
Findings:
- Long-term steroid use can lead to high-level asymptomatic JC viruria even in immunocompetent individuals.
- This contrasts with the typical understanding of JCV shedding in healthy populations.
- The findings highlight a potential risk associated with immunosuppression.
Implications:
- This case underscores the importance of monitoring for opportunistic infections during prolonged immunosuppressive therapy.
- It suggests that steroid therapy can reactivate or increase shedding of latent viruses like JCV.
- Further research may be needed to understand the threshold of immunosuppression leading to significant JC viruria.
Related Concept Videos
Cytomegalovirus Disease
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Viral Hepatitis I: Introduction
Cryptococcal Meningitis
Graves Disease II: Pathophysiology
